Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery


ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

HDL - Cholesterol: The New Target for Treatment

Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Ashraf Ganie

Volume 4 , Issue 2 , 2010

Page: [153 - 160] Pages: 8

DOI: 10.2174/187221410791196605

Price: $65


In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.

Keywords: HDL cholesterol, hyperlipidemia, niacin, fibrates, statins

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy